Table 2.
Chemotherapeutic drugs.
| Alkylating Agents | Drugs | Mechanism of Anti-Tumor or Action |
|---|---|---|
| Nitrogen mustards: | busulfan, chlorambucil, melplatin | Proliferation block by creating inter- or intra-strand cross links in DNA, or |
| Platinum based: | cisplatin, carboplatin, oxalplatin | causing DNA base mispair, thereby |
| Qxazaphosphorines: | cyclophosphamide, ifosfamide | preventing strand separation during cell cycle progression |
| Hydrazine | ||
| Carmustine | ||
| Antimetabolites | ||
| Purine analogs: | 6-mercaptopurine, azathioprine, cladribine | Proliferation or cell cycle block by: |
| Purine antagonists: | fludarabine | interference with biosynthetic pathways, |
| Pyrimidine antagonists: | cytarabine, 5-fluorouracil (5-FU), gemcitabine, capecitabine | disturbance of DNA/RNA formation, |
| Antifolates | methothrexate, pemetrexed, pralatrexate | causing DNA strand breaks, and |
| Inhibitors of ribonucleotide reductase | hydroxyurea | Incorporation of false analogues. These events ultimately can trigger apoptosis. |
| Mitotic Spindle Poisons (Mitosis Poisons) | ||
| Taxans: | docetaxel, paclitaxel, cabazitaxel | Preventing depolymerization of mitotic spindle by stabilizing GDP-bound tubulin in microtubule. |
| Vinca alkaloids: | vincristine, vinblastine, vinorelbine, vindesine, vinflunine | Preventing mitotic spindle formation by inhibition of tubulin polymerization. |
| Others | ||
| Antibiotics: | bleomycin, actinomycin D, anthracyclines | Intercalates into DNA stopping transcription. |
| Proteasome inhibitors | bortezomib | Apoptotic cell death. |
| Tyrosine kinase inhibitors: | imatinib, erlotinib | Affecting multiple signaling pathways. |
| Enzymes | l-asparaginase | Deregulates normal metabolism. |
| Topoisomerase I; inhibitors: | irinotecan, topotecan | DNA strand breaks during replication and |
| Topoisomerase II; inhibitors: | etoposide, anthracyclines: doxorubicin, | causing cell cycle block, and indirectly apoptosis. |